BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 15985032)

  • 1. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial.
    Gupta AK; Skinner AR; Cooper EA
    Int J Dermatol; 2005 Jul; 44(7):590-3. PubMed ID: 15985032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciclopirox gel in the treatment of patients with interdigital tinea pedis.
    Aly R; Fisher G; Katz I; Levine N; Lookingbill DP; Lowe N; Menter A; Morman M; Pariser DM; Roth HL; Savin RC; Shavin JS; Stewart D; Taylor JR; Tucker S; Wortzman M
    Int J Dermatol; 2003 Sep; 42 Suppl 1():29-35. PubMed ID: 14567368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
    J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
    Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
    Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interdigital tinea pedis (dermatophytosis simplex and complex) and treatment with ciclopirox 0.77% gel.
    Gupta AK; Skinner AR; Cooper EA
    Int J Dermatol; 2003 Sep; 42 Suppl 1():23-7. PubMed ID: 12895184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
    Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
    J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials.
    Elewski BE; Vlahovic TC
    J Drugs Dermatol; 2014 Jul; 13(7):803-8. PubMed ID: 25007362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage.
    Abeck D;
    Int J Dermatol; 2004 Jul; 43 Suppl 1():13-6. PubMed ID: 15271195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial.
    Altmeyer P; Hoffmann K;
    Int J Dermatol; 2004 Jul; 43 Suppl 1():9-12. PubMed ID: 15271194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of ciclopirox olamine cream for the treatment of tinea pedis: multicenter, double-blind comparative studies.
    Clin Ther; 1985; 7(4):409-17. PubMed ID: 3893700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo.
    Shuster S; Meynadier J; Kerl H; Nolting S
    Arch Dermatol; 2005 Jan; 141(1):47-52. PubMed ID: 15655141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy between two itraconazole generic products and the innovative itraconazole in the treatment of tinea pedis.
    Hoharitanon S; Chaichalotornkul J; Sindhupak W
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S167-72. PubMed ID: 16623023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis--comparison between three groups (1%, 0.5%, 0.1%) by a multi-center randomised double-blind study.
    Watanabe S; Takahashi H; Nishikawa T; Takiuchi I; Higashi N; Nishimoto K; Kagawa S; Yamaguchi H; Ogawa H
    Mycoses; 2007 Jan; 50(1):35-40. PubMed ID: 17302746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%.
    Clin Ther; 1985; 7(5):574-83. PubMed ID: 2865009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis.
    Leenutaphong V; Niumpradit N; Tangwiwat S; Sritaveesuwan R; Muanprasat C
    J Med Assoc Thai; 1999 Oct; 82(10):1006-10. PubMed ID: 10561963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of 40% urea cream in the treatment of moccasin tinea pedis.
    Elewski BE; Haley HR; Robbins CM
    Cutis; 2004 May; 73(5):355-7. PubMed ID: 15186053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial.
    Lebwohl M; Plott T
    Int J Dermatol; 2004 Jul; 43 Suppl 1():17-20. PubMed ID: 15271196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naftifine gel in the treatment of tinea pedis: two double-blind, multicenter studies. Naftifine Gel Study Group.
    Cutis; 1991 Jul; 48(1):85-8. PubMed ID: 1868748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.